HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Hong Liu Selected Research

3-aminobutyric acid

3/2020Simultaneous determination of thirteen substances related to NAFLD in mouse brain tissue using 3-aminobutyric acid as internal standard by HPLC-FLD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Hong Liu Research Topics

Disease

4Epilepsy (Aura)
11/2019 - 11/2008
3Neoplasms (Cancer)
03/2020 - 10/2016
3Seizures (Absence Seizure)
11/2019 - 12/2012
2Ischemia
06/2021 - 03/2013
1Parkinsonian Disorders (Parkinsonism)
07/2021
1Parkinson Disease (Parkinson's Disease)
07/2021
1Brain Ischemia (Cerebral Ischemia)
06/2021
1Body Weight (Weight, Body)
12/2020
1Non-alcoholic Fatty Liver Disease
03/2020
1Thyroid Neoplasms (Thyroid Cancer)
06/2019
1Sleepiness
05/2019
1Cataplexy
05/2019
1Narcolepsy
05/2019
1Border Disease
01/2019
1Encephalitis (Encephalitis, Rasmussen)
10/2017
1Craniocerebral Trauma (Head Injury)
10/2017
1Myotonia
10/2017
1Epilepsia Partialis Continua
10/2017
1Juvenile Myoclonic Epilepsy
01/2016
1Stroke (Strokes)
07/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1Lipoma (Lipomata)
03/2013
1Hypoxia (Hypoxemia)
03/2013
1Eosinophilia
12/2012
1Alzheimer Disease (Alzheimer's Disease)
03/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2012
1Poisoning
11/2009
1Brain Injuries (Brain Injury)
11/2008
1Temporal Lobe Epilepsy
11/2008
1Status Epilepticus (Complex Partial Status Epilepticus)
11/2008

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
10/2017 - 12/2012
2Pilocarpine (Ocusert)FDA LinkGeneric
07/2009 - 11/2008
1Amino AcidsFDA Link
06/2021
1naringeninIBA
06/2021
1salicylhydroxamic acid (SHAM)IBA
06/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2021
1oxiracetamIBA
12/2020
1chaetoglobosinsIBA
03/2020
13-aminobutyric acidIBA
03/2020
1Branched-Chain Amino AcidsIBA
03/2020
1APTIBA
11/2019
1Tyrosine Kinase InhibitorsIBA
06/2019
1vinyltriethoxysilane (VTES)IBA
06/2019
1Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
05/2019
1Modafinil (Provigil)FDA Link
05/2019
1Methylphenidate (Ritalin)FDA LinkGeneric
05/2019
1Antidepressive Agents (Antidepressants)IBA
05/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Carbamazepine (Tegretol)FDA LinkGeneric
10/2017
1erucylphosphocholineIBA
10/2017
1Topiramate (Topamax)FDA LinkGeneric
10/2017
1PhorbolsIBA
10/2016
1DiterpenesIBA
10/2016
1glyciteinIBA
01/2015
1Phytoestrogens (Phytoestrogen)IBA
01/2015
1IsoflavonesIBA
01/2015
1Immunoglobulin E (IgE)IBA
03/2014
1Chemokine CXCL12IBA
03/2013
1Small Interfering RNA (siRNA)IBA
03/2013
1SteroidsIBA
12/2012
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2012
1Levetiracetam (Keppra)FDA LinkGeneric
12/2012
1CateninsIBA
03/2012
1EstersIBA
11/2009
1Phosphates (Orthophosphate)IBA
11/2009
1tri-o-cresyl phosphate (TOCP)IBA
11/2009
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2009
1Serine (L-Serine)FDA Link
07/2009
1Proteins (Proteins, Gene)FDA Link
11/2008
1Coloring Agents (Dyes)IBA
11/2008
1fluoro-jade CIBA
11/2008

Therapy/Procedure

3Therapeutics
05/2019 - 03/2012
1Ambulatory Care (Outpatient Care)
07/2021
1Ligation
12/2020
1Aftercare (After-Treatment)
05/2019
1Smart Glasses
07/2015
1Lipectomy (Liposuction)
03/2013